Unknown

Dataset Information

0

MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription.


ABSTRACT: Excessive fibrogenic response in the liver disrupts normal hepatic anatomy and function heralding such end-stage liver diseases as hepatocellular carcinoma and cirrhosis. Sinusoidal endothelial cells contribute to myofibroblast activation and liver fibrosis by undergoing endothelial-mesenchymal transition (EndMT). The underlying mechanism remains poorly defined. Here we report that inhibition or endothelial-specific deletion of MKL1, a transcriptional modulator, attenuated liver fibrosis in mice. MKL1 inhibition or deletion suppressed EndMT induced by TGF-?. Mechanistically, MKL1 was recruited to the promoter region of TWIST1, a master regulator of EndMT, and activated TWIST1 transcription in a STAT3-dependent manner. A small-molecule STAT3 inhibitor (C188-9) alleviated EndMT in cultured cells and bile duct ligation (BDL) induced liver fibrosis in mice. Finally, direct inhibition of TWIST1 by a small-molecule compound harmine was paralleled by blockade of EndMT in cultured cells and liver fibrosis in mice. In conclusion, our data unveil a novel mechanism underlying EndMT and liver fibrosis and highlight the possibility of targeting the STAT3-MKL1-TWIST1 axis in the intervention of aberrant liver fibrogenesis.

SUBMITTER: Li Z 

PROVIDER: S-EPMC6881349 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription.

Li Zilong Z   Chen Baoyu B   Dong Wenhui W   Kong Ming M   Fan Zhiwen Z   Yu Liming L   Wu Dongmei D   Lu Jun J   Xu Yong Y  

Cell death & disease 20191127 12


Excessive fibrogenic response in the liver disrupts normal hepatic anatomy and function heralding such end-stage liver diseases as hepatocellular carcinoma and cirrhosis. Sinusoidal endothelial cells contribute to myofibroblast activation and liver fibrosis by undergoing endothelial-mesenchymal transition (EndMT). The underlying mechanism remains poorly defined. Here we report that inhibition or endothelial-specific deletion of MKL1, a transcriptional modulator, attenuated liver fibrosis in mice  ...[more]

Similar Datasets

| S-EPMC7472197 | biostudies-literature
| S-EPMC7272438 | biostudies-literature
| S-EPMC8285099 | biostudies-literature
| S-EPMC7066128 | biostudies-literature
| S-EPMC2937229 | biostudies-literature
| S-EPMC6378632 | biostudies-literature
| S-EPMC8386622 | biostudies-literature
| S-EPMC6091192 | biostudies-literature
| S-EPMC6080604 | biostudies-literature
| S-EPMC4537852 | biostudies-literature